APA (7th ed.) Citation

Watson, C. H., Gsell, P., Hall, Y., Camacho, A., Riveros, X., Enwere, G., . . . Camara, M. N. (2024). rVSV-ZEBOV vaccination in people with pre-existing immunity to Ebolavirus: An open-label safety and immunogenicity study in Guinean communities affected by Ebola virus disease (l'essai proches). BMC Medicine, 22(1), 1. https://doi.org/10.1186/s12916-024-03726-z

Chicago Style (17th ed.) Citation

Watson, Conall H., et al. "RVSV-ZEBOV Vaccination in People with Pre-existing Immunity to Ebolavirus: An Open-label Safety and Immunogenicity Study in Guinean Communities Affected by Ebola Virus Disease (l'essai Proches)." BMC Medicine 22, no. 1 (2024): 1. https://doi.org/10.1186/s12916-024-03726-z.

MLA (9th ed.) Citation

Watson, Conall H., et al. "RVSV-ZEBOV Vaccination in People with Pre-existing Immunity to Ebolavirus: An Open-label Safety and Immunogenicity Study in Guinean Communities Affected by Ebola Virus Disease (l'essai Proches)." BMC Medicine, vol. 22, no. 1, 2024, p. 1, https://doi.org/10.1186/s12916-024-03726-z.